Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment

Background Blood transcriptomic studies in Alzheimer's disease (AD) often train signatures directly in blood, making it unclear whether signals reflect brain disease programs, blood-cell composition, or cohort structure. Objective To test how neuropathology-defined AD transcriptional programs appear in blood, whether distinct brain programs show a shared peripheral pattern, and whether that pattern is most evident during mild cognitive impairment (MCI). Methods Three directional gene sets were derived before blood analysis from postmortem brain RNA-seq (GSE278723) to represent amyloid-associated, neurodegeneration-related, and core AD changes. These brain-defined programs were projected into five whole-blood cohorts (1975 participants) using directional single-sample Gene Set Enrichment Analysis and assessed for stage-specific patterns, comparison with size-matched random sets, sensitivity to estimated cell composition, dimensionality, held-out classification, and association with Alzheimer's Disease Neuroimaging Initiative (ADNI) genetic and fluid biomarkers. Results Brain-derived AD programs were detected across blood cohorts and showed a shared rather than separable pattern. Scores were highest at MCI, exceeded size-matched random baselines, and were not primarily explained by estimated blood-cell proportions. In GSE63060, P1/P2/P5 scores formed a dominant axis, with PC1 explaining 92.2% of directional half-score variance. A held-out classifier achieved AUC = 0.822, and ADNI analyses showed information beyond APOE ε4 and improved discrimination when blood scores were combined with cerebrospinal fluid pTau181/Aβ 42 . Conclusions Neuropathology-defined AD transcriptomic programs form a shared peripheral axis that is most evident at MCI. This brain-anchored signal adds a systemic transcriptional dimension to genetic and fluid biomarkers and provides a biological framework for studying early AD-related disease in blood.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2026-11-19
DOI
https://doi.org/10.1177/13872877261507716
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment

Xiaohui Hou, Xingjiao Wu, Songnian Lu, Hongyuan Mao et al.
Journal of Alzheimer s Disease
Dementia and Cognitive Impairment Research
article

Neuropathology-defined Alzheimer's disease transcriptomic programs converge in blood at mild cognitive impairment

Xiaohui Hou, Xingjiao Wu, Songnian Lu, Hongyuan Mao, Mengcen Qian, Alzheimer’s Disease Neuroimaging Initiative *, Xiaoya Rui
article en

Abstract

Background Blood transcriptomic studies in Alzheimer's disease (AD) often train signatures directly in blood, making it unclear whether signals reflect brain disease programs, blood-cell composition, or cohort structure. Objective To test how neuropathology-defined AD transcriptional programs appear in blood, whether distinct brain programs show a shared peripheral pattern, and whether that pattern is most evident during mild cognitive impairment (MCI). Methods Three directional gene sets were derived before blood analysis from postmortem brain RNA-seq (GSE278723) to represent amyloid-associated, neurodegeneration-related, and core AD changes. These brain-defined programs were projected into five whole-blood cohorts (1975 participants) using directional single-sample Gene Set Enrichment Analysis and assessed for stage-specific patterns, comparison with size-matched random sets, sensitivity to estimated cell composition, dimensionality, held-out classification, and association with Alzheimer's Disease Neuroimaging Initiative (ADNI) genetic and fluid biomarkers. Results Brain-derived AD programs were detected across blood cohorts and showed a shared rather than separable pattern. Scores were highest at MCI, exceeded size-matched random baselines, and were not primarily explained by estimated blood-cell proportions. In GSE63060, P1/P2/P5 scores formed a dominant axis, with PC1 explaining 92.2% of directional half-score variance. A held-out classifier achieved AUC = 0.822, and ADNI analyses showed information beyond APOE ε4 and improved discrimination when blood scores were combined with cerebrospinal fluid pTau181/Aβ 42 . Conclusions Neuropathology-defined AD transcriptomic programs form a shared peripheral axis that is most evident at MCI. This brain-anchored signal adds a systemic transcriptional dimension to genetic and fluid biomarkers and provides a biological framework for studying early AD-related disease in blood.

Journal of Alzheimer s Disease
East China University of Science and Technology (CN), Fudan University (CN), East China Normal University (CN)
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon